#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2364	469.7	0	.	n	.	0	C451T	SNP	451	451	C	822	822	T	661	T,C,A	480,164,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2364	469.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1555	1555	C	549	C	539	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	11188	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2364	469.7	0	HET	.	.	.	C207T,G	.	207	207	C	578	578	C	629	C,T,G	470,134,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20496	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3624	561.8	0	.	n	.	0	T695C	SNP	695	695	T	1036	1036	C	577	C	569	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20496	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3624	561.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2312	2312	C	646	C	631	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20496	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3624	561.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2386	2386	A	638	A	625	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20496	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3624	561.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2938	2938	C	680	C,G	671,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	20496	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3624	561.8	0	HET	.	.	.	A1638G	.	1638	1638	A	1979	1979	A	635	A,G	498,134	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1496	folP	855	855	100.0	folP.l15.c4.ctg.1	1512	97.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1057	1059	AGC	139;140;140	A;G;C	133;137;132	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	120.4	1	SNP	p	S91F	1	.	.	271	273	TTC	591	593	TTC	143;144;143	T;T;C,T	142;143;142,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	120.4	1	SNP	p	G95N	0	.	.	283	285	GGC	603	605	GGC	145;144;143	G;G;C	140;140;139	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	120.4	1	SNP	p	D95G	1	.	.	283	285	GGC	603	605	GGC	145;144;143	G;G;C	140;140;139	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1424	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1298	108.8	1	SNP	p	G45D	0	.	.	133	135	GGC	450	452	GGC	179;176;176	G,T;G;C	174,1;171;174	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	696	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1034	66.9	0	.	n	.	0	A197.	DEL	197	197	A	612	612	A	163	A	162	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3580	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3121	114.1	1	SNP	p	D86N	0	.	.	256	258	GAC	634	636	GAC	158;157;157	G;A;C	155;152;154	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3580	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3121	114.1	1	SNP	p	S87R	1	.	.	259	261	CGT	637	639	CGT	157;156;156	C,A;G;T,C	152,2;153;150,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3580	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3121	114.1	1	SNP	p	R87I	0	.	.	259	261	CGT	637	639	CGT	157;156;156	C,A;G;T,C	152,2;153;150,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3580	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3121	114.1	1	SNP	p	R87W	0	.	.	259	261	CGT	637	639	CGT	157;156;156	C,A;G;T,C	152,2;153;150,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3580	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3121	114.1	1	SNP	p	S88P	0	.	.	262	264	TCC	640	642	TCC	156;157;158	T;C;C	152;154;156	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3212	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2712	117.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1591	1593	GGC	162;157;156	G;G;C	161;152;153	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1276	1278	GCC	165;167;167	G;C;C	162;165;161	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1279	1281	ATG	167;166;167	A;T;G	164;164;166	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1291	1293	ACC	171;173;172	A;C;C	166;169;166	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1291	1293	ACC	171;173;172	A;C;C	166;169;166	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1792	1794	ACC	149;149;150	A;C;C	139;144;143	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1846	1848	GCG	151;151;150	G;C,G;G	151;148,1;150	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1846	1848	GCG	151;151;150	G;C,G;G	151;148,1;150	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1969	1971	GGT	115;114;113	G,A;G;T,C	113,2;114;108,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1978	1980	AGC	111;112;111	A,G;G;C	106,2;112;108	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3016	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2410	123.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1996	1998	CCG	80;81;80	C,G;C;G	78,1;78;74	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4486	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3305	134.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1767	1769	CCG	136;137;138	C;C,T,A;G,A	125;129,2,1;130,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1928	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1884	100.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	122	C	111	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	0	.	p	.	0	I75V	NONSYN	223	225	ATT	472	474	GTT	173;173;175	G,C;T;T	161,1;150;170	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	0	.	p	.	0	S89T	NONSYN	265	267	AGC	514	516	ACC	147;147;150	A,C;C;C	138,1;142;147	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	0	.	p	.	0	I98V	NONSYN	292	294	ATC	541	543	GTC	148;147;151	G;T,C;C	136;135,1;142	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	1	SNP	p	G120K	1	.	.	358	360	AAG	607	609	AAG	158;159;159	A;A;G,A	153;158;151,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	1	SNP	p	A121N	1	.	.	361	363	AAC	610	612	AAC	160;160;161	A,G;A;C	155,1;157;159	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2204	porB1b	1038	1038	99.61	porB1b.l6.c4.ctg.1	1500	144.5	1	SNP	p	N121D	0	.	.	361	363	AAC	610	612	AAC	160;160;161	A,G;A;C	155,1;157;159	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7132	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4946	142.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	830	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1088	75.3	1	SNP	p	V57M	1	.	.	169	171	ATG	600	602	ATG	149;151;152	A,G;T;G	147,1;150;152	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
